Page last updated: 2024-08-25

almagate and Benign Neoplasms, Brain

almagate has been researched along with Benign Neoplasms, Brain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanwar, JR; Kanwar, R; Sriramoju, B; Veedu, RN1
Claes, A; Hovinga, KE; Leenders, WP; Musters, GD; Peter Vandertop, W; Richel, DJ; Stalpers, LJ; van Furth, WR; Verhoeff, JJ1

Reviews

1 review(s) available for almagate and Benign Neoplasms, Brain

ArticleYear
Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Current topics in medicinal chemistry, 2015, Volume: 15, Issue:12

    Topics: Alzheimer Disease; Aptamers, Nucleotide; Aptamers, Peptide; Blood-Brain Barrier; Brain Neoplasms; Drug Delivery Systems; Humans; Macular Degeneration; Molecular Targeted Therapy; Multiple Sclerosis; Myasthenia Gravis; Parkinson Disease; SELEX Aptamer Technique; Stroke; Theranostic Nanomedicine

2015

Other Studies

1 other study(ies) available for almagate and Benign Neoplasms, Brain

ArticleYear
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:17

    Topics: Angiogenesis Inhibitors; Animals; Aptamers, Nucleotide; Brain Neoplasms; Combined Modality Therapy; Disease Models, Animal; Disease-Free Survival; Female; Glioblastoma; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Treatment Outcome; Vascular Endothelial Growth Factor A

2009